Spectralytics, Cordis Stent Case Cleared For Trial

Law360, New York (September 16, 2008, 12:00 AM EDT) -- A federal judge has allowed a stent patent lawsuit filed by medical device company Spectralytics Inc. against rivals Cordis Corp. and Norman Noble Inc. to go to trial, denying some motions for summary judgment from both sides.

Judge Patrick J. Schiltz of the U.S. District Court for the District of Minnesota denied a motion for summary judgment by Cordis that the patent Spectralytics is asserting in the case — U.S. Patent Number 5,852,277 — is invalid due to obviousness, though he said that Cordis was likely...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.